Fluoroquinolone Antibiotics in the Environment

  • Premasis Sukul
  • Michael Spiteller
Part of the Reviews of Environmental Contamination and Toxicology book series (RECT, volume 191)


The occurrence of human and veterinary pharmaceuticals in soil and water (Thiele-Bruhn 2003; Snyder et al. 2003; Hamscher et al. 2004; Kay et al. 2004) has led to increased research activities among environmental scientists to find out their possible environmental threats. As antibiotics are used for human and animal medical care, there is a possibility for these drugs to reach the environment via direct or indirect contamination (Thiele-Bruhn 2003; Boxall et al. 2004). As they are produced and applied with the aim of being biologically highly effective, their occurrence is of ecotoxicological interest. In Berlin, Germany, the groundwater wells located near contaminated surface waters showed a concentration of pharmaceuticals at the µg/L level (Heberer 2002). Thus, at such a level of contamination, the use of groundwater for drinking purposes may pose a potential risk. Studies on the behavior of animal drugs and their metabolites after excretion, along with their transport from agricultural sources into surface water and groundwater by overland-flow runoff and leaching, are of utmost importance at present.


Sewage Sludge Anal Chim Oxolinic Acid Photodegradation Product Fluoroquinolone Antibiotic 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahel M, Jeličic I (2001) Phenazone analgesics in soil and ground water below a municipal solid waste landfill. In: Daughton CG, Jones-Lepp TL (eds) Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues. Symposium Series 791. American Chemical Society, Washington, DC, pp 100–115.Google Scholar
  2. Al-Ahmad A, Daschner FD, Kümmerer K (1999) Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G and sulfamethoxazole and inhibition of waste water bacteria. Arch Environ Contam Toxicol 37:158–163.Google Scholar
  3. Alder AC, McArdell CS, Golet EM, Ibric S, Molnar E, Nipales NS, Giger W (2001) Occurrence and fate of fluoroquinolone, macrolide, and sulfonamide antibiotics during wastewater treatment and in ambient waters in Switzerland. In: Daughton CG, Jones-Lepp TM (eds) Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues. Symposium Series 791. American Chemical Society, Washington, DC, pp 56–69.Google Scholar
  4. Alder AC, Golet EM, Giger W, Siegrist H (2003) Environmental exposure of fluoroquinolone antibacterial agents in wastewater and river water in Switzerland. Presented at ENVIRPHARMA, European Conference on Human and Veterinary Pharmaceuticals in the Environment, Lyon, France, April 14–16, 2003.Google Scholar
  5. Alder AC, McArdell CS, Golet EM, Kohler HPE, Molnar E, Pham Thi NA, Siegrist H, Suter MJF, Giger W (2004) Environmental exposure of antibiotics in wastewaters, sewage sludges and surface waters in Switzerland. In: Kümmerer K (ed) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 2nd Ed. Springer-Verlag, Berlin, pp 55–66.Google Scholar
  6. Andreozzi R, Rafaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319–1330.Google Scholar
  7. Araki T, Kawai Y, Ohta I, Kitaoka H (2002) Photochemical behavior of sitafloxacin, fluoroquinolone antibiotic, in an aqueous solution. Chem Pharmaceut Bull 50: 229–234.Google Scholar
  8. Asami S, Hatsugai K, Osawa K, Nakabayashi Y, Nakajima T (2000) Confirmation of quinolone antibacterials in porcine meat and kidneys by gas chromatography/mass spectrometry using selected ion monitoring. Nippon Juishikai Zasshi 53: 225–231.Google Scholar
  9. Azerad R (1999) Microbial models for drug metabolism. Adv Biochem Eng Biotechnol 63:169–218.Google Scholar
  10. Barbosa J, Barrón D, Jiménez-Lozano E, Sanz-Nebot V (2001) Comparison between capillary electrophoresis, liquid chromatography, potentiometric and spectrophotometric techniques for evaluation of pKa values of zwitterionic drugs in acetonitrile-water mixtures. Anal Chim Acta 437:309–321.Google Scholar
  11. Barrón D, Jiménez-Lozano E, Bailac S, Barbosa J (2002) Determination of difloxacin and sarafloxacin in chicken muscle using solid-phase extraction and capillary electrophoresis. J Chromatogr B 767:313–319.Google Scholar
  12. Barrón D, Jiménez-Lozano E, Bailac S, Barbosa J (2003) Simultaneous determination of flumequine and oxolinic acid in chicken tissues by solid-phase extraction and capillary electrophoresis. Anal Chim Acta 477:21–27.Google Scholar
  13. Bhanot SK, Singh M, Chatterjee NR (2001) The chemical and biological aspects of fluoroquinolones: reality and dreams. Curr Pharm Design 7:313–337.Google Scholar
  14. Bilanzierung der Nährstoffausscheidungen Landwirtschatlicher Nutztiere (2005) Arbeiten der DLG, Band 199.Google Scholar
  15. Björklund H, Råbergh CMI, Bylund G (1991) Residues of oxolinic acid and oxytetracycline in fish and sediments from fish farms. Thesis. Department of Biology, Åbo Akademi University, Finland.Google Scholar
  16. Booth DM (1994) Enrofloxacin revisited. Vet Med 8:744–753.Google Scholar
  17. Borner K, Borner E, Hartwig H, Lode H (1990) HPLC of recent quinolone antimicrobials. In: Reid E, Wilson ID (eds) Analysis for Drugs and Metabolites, Including Antiinfective Agents. Royal Society of Chemistry, Cambridge, England, pp 131–144.Google Scholar
  18. Boxall ABA, Fogg LA, Kay P, Blackwell PA, Pemberton EJ (2002) Review of veterinary medicines in the environment. Environment Agency R + D Technical Report P. Environment Agency, Bristol, UK.Google Scholar
  19. Boxall ABA, Kolpin DW, Halling-Sørensen B, Tolls J (2003) Are veterinary medicines causing environmental risks? Environ Sci Technol 37:286–294.Google Scholar
  20. Boxall ABA, Fogg LA, Blackwell PA, Kay P, Pemberton EJ, Croxford A (2004) Veterinary medicines in the environment. Rev Environ Contam Toxicol 180:1–91.Google Scholar
  21. Bryskier A, Chantot JF (1995) Classification and structure-activity relationships of fluoroquinolones. Drugs 49:16–28.Google Scholar
  22. Burhenne J, Ludwig M, Nikoloudis P, Spiteller M (1997a) Photolytic degradation of fluoroquinolone carboxylic acids in aqueous solution. Part I: primary photoproducts and half-lives. Environ Sci Pollut Res 4:10–15.Google Scholar
  23. Burhenne J, Ludwig M, Spiteller M (1997b) Photolytic degradation of fluoroquinolone carboxylic acids in aqueous solution. Part II: Isolation and structural elucidation of polar photometabolites. Environ Sci Pollut Res 4:61–67.Google Scholar
  24. Chen Y, Rosazza JPN, Reese CP, Chang HY, Nowakowski MA, Kiplinger JP (1997) Microbial models of soil metabolism: biotransformation of danofloxacin. J Ind Microbiol Biotechnol 19:378–384.Google Scholar
  25. Chiu CH, Wu TL, Su LH (2002) The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 346:413–419.Google Scholar
  26. Choma IM (2003) TLC separation of fluoroquinolones: searching for better selectivity. J Liquid Chromatogr Relat Technol 26:2673–2685.Google Scholar
  27. Choma IM, Choma A, Staszczuk K (2002) Determination of flumequine in milk by thin-layer chromatography-bioautography. J Liq Chromatogr Relat Technol 25:1579–1587.Google Scholar
  28. Christian T, Schneider RJ, Färber HA, Skutlarek D, Meyer MT, Goldbach HE (2003) Determination of antibiotic residues in manure, soil, and surface waters. Acta Hydrochim Hydrobiol 31:36–44.Google Scholar
  29. Cinquina AL, Roberti P, Giannetti L, Longo F, Draisci R, Fagiolo A, Brizioli NR (2003) Determination of enrofloxacin and its metabolite ciprofloxacin in goat milk by HPLC with diode-array detection. Optimization and validation. J Chromatogr A 987:221–226.Google Scholar
  30. Dalhoff A, Bergan T (1998) Pharmacokinetics of fluoroquinolones in experimental animals. In: Kuhlmann J, Dalhoff A, Zeiler H-J (eds) Quinolone Antibacterials. Springer-Verlag, Berlin, pp 179–206.Google Scholar
  31. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Special report. Environ Health Perspect 107:907–938.Google Scholar
  32. Davis IM, Lofthouse TJ, Stamm JM (1993) Aquatic photodegradation of 14Csarafloxacin hydrochloride. Abstr Pap Am Chem Soc 205:91.Google Scholar
  33. Delepine B, Hurtaud-Pessel D, Sanders P (1998) Simultaneous determination of six quinolones in pig muscles by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry. Analyst 123:2743–2747.Google Scholar
  34. Du LM, Lin AP, Yang YQ (2004a) Spectrofluorometric determination of certain quinolone through charge transfer complex formation. Anal Lett 37:2175–2188.Google Scholar
  35. Du LM, Yang YQ, Wang QM (2004b) Spectrofluorometric determination of certain quinolone through charge transfer complex formation. Anal Chim Acta 516:237–243.Google Scholar
  36. Edlund C, Lindqvist L, Nord CE (1988) Norfloxacin binds to human fecal material. Antimicrob Agents Chemother 32:1869–1874.Google Scholar
  37. Ervik A, Thorsen B, Eriksen V, Lunestad BT, Samuelsen OB (1994) Impact of administering antibacterial agents on wild fish and blue mussels Mytilus edulis in the vicinity of fish farms. Dis Aquat Org 18:45–51.Google Scholar
  38. Fasani E, Rampi M, Albini A (1999) Photochemistry of some fluoroquinolones: effect of pH and chloride ion. J Chem Soc Perkin Trans 29:1901–1907.Google Scholar
  39. Fasani E, Mella M, Monti S, Albini A (2001) Unexpected photoreactions of some 7-amino-6-fluoroquinolones in phosphate buffer. Eur J Org Chem 2:391–397.Google Scholar
  40. FEDESA (2001) Antibiotic use in farm animals does not threaten human health. FEDESA/FEFANA press release, European Federation of Animal Health, Brüssels, July 13, 2001.Google Scholar
  41. FAO/OIE/WHO (2003) Evidence of association between non-human usage of antimicrobial agents and antimicrobial resistance in humans. In: Proceedings-Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific assessment, December 1–5, 2003, Geneva, Switzerland, pp 11–15.Google Scholar
  42. Garcia MA, Solans C, Calvo A, Hernandez E, Rey R, Bregante MA, Puig M (2005) Determination of enrofloxacin and its primary metabolite, ciprofloxacin, in pig tissues: application to residue studies. Biomed Chromatogr 19:27–31.Google Scholar
  43. Golet EM, Alder AC, Hartmann A, Ternes TA, Giger W (2001) Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal Chem 73:3632–3638.Google Scholar
  44. Golet EM, Alder AC, Giger W (2002a) Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. Environ Sci Technol 36:3645–3651.Google Scholar
  45. Golet EM, Strehler A, Alder AC, Giger W (2002b) Determination of fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction. Anal Chem 74: 5455–5462.Google Scholar
  46. Golet EM, Xifra I, Siegrist H, Alder AC, Giger W (2003) Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ Sci Technol 37:3243–3249.Google Scholar
  47. Grellet J, Ba B, Saux MC (2002) High-performance liquid chromatographic separation of fluoroquinolone enantiomers: a review. J Biochem Biophys Methods 54:221–233.Google Scholar
  48. Griffin DM (1972) Ecology of Soil Fungi. Chapman & Hall, London.Google Scholar
  49. Halling-Sørensen B, Nielsen SN, Lanzky PF, Ingerslev F, Holten Lützhoft HC, Jorgensen SE (1998) Occurrence, fate and effect of pharmaceutical substances in the environment: a review. Chemosphere 36:357–393.Google Scholar
  50. Halling-Sørensen B, Holten Lützhoft HC, Andersen HR, Ingerslev F (2000) Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin. J Antimicrob Chemother 46:53–58.Google Scholar
  51. Halling-Sørensen B, Sengeløv G, Ingerslev F, Jensen LB (2003) Reduced antimicrobial potencies of oxytetracycline, tylosin, sulfadiazine, streptomycin, ciprofloxacin, and olaquindox due to environmental processes. Arch Environ Contam Toxicol 44:7–16.Google Scholar
  52. Hamscher G, Sczesny S, Abu-Quare A, Hörper H, Nau H (2000) Substances with pharmacological effects including hormonally active substances in the environment: identification of teteracyclines in soil fertilized with animal slurry. Dtsch Tierärztl Wochenschr 107:293–348.Google Scholar
  53. Hamscher G, Powelzick HT, Höper H, Nau H (2004) Antibiotics in soil: routes of entry, environmental concentrations, fate and possible effects. In: Kümmerer K (ed) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 2nd Ed. Springer-Verlag, Berlin, pp 139–147.Google Scholar
  54. Hartmann A, Alder AC, Koller T, Widmer RM (1998) Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater. Environ Toxicol Chem 17:377–382.Google Scholar
  55. Hartmann A, Golet EM, Gartiser S, Alder AC, Koller T, Widmer RM (1999) Primary DNA damage but not mutagenecity correlates with ciprofloxacin concentrations in German hospital wastewaters. Arch Environ Contam Toxicol 36:115–119.Google Scholar
  56. Heberer T (2002) Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 266:175–189.Google Scholar
  57. Hektoen H, Berge JA, Hormazabal V, Yndestad M (1995) Persistence of antibacterial agents in marine sediments. Aquaculture 133:175–184.Google Scholar
  58. Hernández M, Borrull F, Calull M (2002) Using non-aqueous capillary electrophoresis to analyze several quinolones in pig kidney samples. Electrophoresis 23:506–511.Google Scholar
  59. Holm JV, Ruegge K, Bjerg PL, Christensen TH (1995) Occurrence and distribution of pharmaceutical organic compounds in the groundwater downgradient of a landfill (Grinsted, Denmark). Environ Sci Technol 29:1415–1420.Google Scholar
  60. Hooper DC, Wolfson JS (1993) Mechanism of quinolone action and bacterial killing. In: Hooper DC, Wolfson JS (eds) Quinolone Antibacterial Agents, 2nd Ed. American Society for Microbiology, Washington DC, pp 53–75.Google Scholar
  61. Ingerslev F, Torang L, Loke ML, Halling-Sørensen B, Nyholm N (2001) Primary biodegradation of veterinary antibiotics in aerobic and anaerobic surface water simulation systems. Chemosphere 44:865–872.Google Scholar
  62. Isidori M, Lavorgna M, Nardelli A, Pascarella L, Parrella A (2005) Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci Total Environ 346:87–98.Google Scholar
  63. Kassenborg HD, Smith KE, Vugia DJ, Rabatsky-Ehr T, Bates MR, Carter MA, Dumas NB, Cassidy MP, Marano N, Tauxe RV, Angulo FJ (2004) Fluoroquinoloneresistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clin Infect Dis 38:279–284.Google Scholar
  64. Kay P, Blackwell PA, Boxall ABA (2004) Fate of veterinary antibiotics in a macroporous tile drained clay soil. Environ Toxicol Chem 23:1136–1144.Google Scholar
  65. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U. S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211.Google Scholar
  66. Kümmerer K (2004) Emissions from medical care units. In: Kümmerer K (ed) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 2nd Ed. Springer-Verlag, Berlin, pp 27–44.Google Scholar
  67. Kümmerer K, Al-Ahmed A, Mersch-Sundermann V (2000) Biodegradability of some antibiotics, elimination of their genotoxicity and affection of waste water bacteria in a simple test. Chemosphere 40:701–710.Google Scholar
  68. Lode H, Höffken G, Prinzing C, Glatzel P, Wiley R, Olschewski P, Sievers B, Reimnitz D, Borner K, Koeppe P (1987) Comparative pharmacokinetics of new quinolones. Drugs 34:21–25.Google Scholar
  69. Lunestad BT, Samuelsen OB, Fjelde S, Ervik A (1995) Photostability of eight antibacterial agents in seawater. Aquaculture 134:217–225.Google Scholar
  70. Lützhøft H-CH, Vaes WHJ, Freidig AP, Halling-Sørensen B, Hermens JLM (2000) Influence of pH and other modifying factors on the distribution behavior of 4-quinolones to solid phases and humic acids studied by “negligible-depletion” SPME-HPLC. Environ Sci Technol 34:4989–4994.Google Scholar
  71. Marazuela MD, Moreno-Bondi MC (2004) Multiresidue determination of fluoroquinolones in milk by column liquid chromatography with fluorescence and ultraviolet absorbance detection. J Chromatogr A 1034:25–32.Google Scholar
  72. Marengo JR, Kok RA, O’Brian K, Velagaleti RR, Stamm JM (1997) Aerobic biodegradation of (14C)-sarafloxacin hydrochloride in soil. Environ Toxicol Chem 16:462–471.Google Scholar
  73. Marengo JR, Kok RA, Burrows LA, Velagaleti RR, Stamm JM (2001) Biodegradation of (14C)-sarafloxacin hydrochloride, a fluoroquinolone antimicrobial, by Phanerochaete chrysosporium. J Sci Ind Res 60:121–130.Google Scholar
  74. Matzen EL, Wammer KH, Werner JH, McNeil K (2005) Aquatic environmental photochemistry and biological activity of fluoroquinolone antibiotics. In: Abstracts of Papers, 229th ACS National Meeting, San Diego, CA, March 13–17, 2005.Google Scholar
  75. Mella M, Fasani E, Albini A (2001) Photochemistry of 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(piperazin-1-yl) quinoline-3-carboxylic acid (ciprofloxacin) in aqueous solutions. Helv Chim Acta 84:2508–2519.Google Scholar
  76. Messi P, Guerrieri E, Bondi M (2005) Antibiotic resistance and antibacterial activity in heterotrophic bacteria of mineral water origin. Sci Total Environ 346:213–219.Google Scholar
  77. Miao X-S, Bishay F, Chen M, Metcalfe CD (2004) Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ Sci Technol 38:3533–3541.Google Scholar
  78. Ministerium für Umwelt, and Naturschutz, Landwirtshaft und Verbraucherschutz des Landes Nordrhein-Westfalen (2006) Düngeverordnung.Google Scholar
  79. Molbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K, Gerner-Smidt P, Petersen AM, Wegener HC (1999) An out-break of multi-drug resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT 104. N Engl J Med 341:1420–1425.Google Scholar
  80. Morais-Cabral JH, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington RC (1997) Crystal structure of breakage-reunion domain of DNA gyrase. Nature (Lond) 388:903–906.Google Scholar
  81. Nakamura R, Yamaguchi T, Sekine Y, Hashimoto M (1983) Determination of new antibacterial agent (AT-2266) and its metabolites in plasma and urine by highperformance liquid chromatography. J Chromatogr 278:321–328.Google Scholar
  82. Nakashima M, Kanamaru M, Uematsu T, Takiguchi A, Mizuno A, Itaya T, Kawahara F, Ooie T, Saito S, Uchida H, Masuzawa K (1988) Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers. J Antimicrob Chemother 22:133–144.Google Scholar
  83. Nakata H, Kannan K, Jones PD, Giesy JP (2005) Determination of fluoroquinolone antibiotics in wastewater effluents by liquid chromatography-mass spectrometry and fluorescence detection. Chemosphere 58:759–766.Google Scholar
  84. Nowara A, Burhenne J, Spiteller M (1997) Binding of fluoroquinolone carboxylic acid derivatives to clay. J Agric Food Chem 45:1459–1463.Google Scholar
  85. OECD (2000) Adsorption/desorption using a batch equilibrium method. OECD guidelines for testing of chemicals: test guideline 106. Revised draft document. OECD, Paris, France, pp 1–26.Google Scholar
  86. Ohlsen K, Ziebuhr W, Koller K, Hell W, Wichelhaus TA, Hacker J (1998) Effects of sub-inhibitory concentrations of antibiotics an alpha-toxon (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 42:2817–2823.Google Scholar
  87. Parshikov IA, Freeman JP, Lay JO, Beger RD, Williams AJ, Sutherland JB (1999) Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. FEMS Microbiol Lett 177:131–135.Google Scholar
  88. Parshikov IA, Freeman JP, Lay JO, Beger RD, Williams AJ, Sutherland JB (2000) Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus. Appl Environ Microbiol 66:2664–2667.Google Scholar
  89. Pecorelli I, Galarini R, Bibi R, Floridi Al, Casciarri E, Floridi A (2003) Simultaneous determination of 13 quinolones from feeds using accelerated solvent extraction and liquid chromatography. Anal Chim Acta 483:81–89.Google Scholar
  90. Pfenning AP, Munnas RK, Turnipseed SB, Roybal JE, Holland DC, Long AR, Plakas SM (1996) Determination and confirmation of identities of flumequine, nalidixic, oxolinic and piromidic acids in salmon and shrimp. J AOAC Int 79:1227–1235.Google Scholar
  91. Pham Thi NA (2003) Determination and occurrence of fluoroquinolone antibacterial agents in hospital waste water. EPFL, Lausanne, Switzerland.Google Scholar
  92. Philips G, Jhonson BE, Ferguson J (1990) The loss of antimicrobial activity of ciprofloxacin by photodegradation. J Antimicrob Chemother 26:783–789.Google Scholar
  93. Renew JE, Huang CH (2004) Simultaneous analysis of fluoroquinolone, sulfonamide and trimethoprim antibiotics in wastewater using tandem solid-phase extraction and liquid chromatography electrospray mass spectrometry. J Chromatogr A 1042:113–121.Google Scholar
  94. Samanidou VF, Christodoulou EA, Papadoyannis IN (2005a) Determination of fluoroquinolones in edible animal tissue samples by high performance liquid chromatography after solid phase extraction. J Sep Sci 28:555–565.Google Scholar
  95. Samanidou VF, Christodoulou EA, Papadoyannis IN (2005b) Direct determination of five fluoroquinolones in chicken whole blood and in veterinary drugs by HPLC. J Sep Sci 28:325–331.Google Scholar
  96. Schneider MJ, Donoghue DJ (2003) Multiresidue determination of fluoroquinolone antibiotics in eggs using liquid chromatography-fluorescence-mass spectrometry. Anal Chim Acta 483:39–49.Google Scholar
  97. Schwartz T, Kohnenb W, Jansenb B, Obsta U (2003) Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS Microbiol Ecol 43:325–335.Google Scholar
  98. Shen JY, Kim MR, Lee CJ, Kim IS, Lee KB, Shim JH (2004) Supercritical fluid extraction of the fluoroquinolones, norfloxacin and ofloxacin from orally treated chicken breast muscles. Anal Chim Acta 513:451–455.Google Scholar
  99. Shim JH, Shen JY, Kim MR, Lee CJ, Kim IS (2003) Determination of the fluoroquinolone enrofloxacin in edible chicken muscle by supercritical fluid extraction and liquid chromatography with fluorescence detection. J Agric Food Chem 51:7528–7532.Google Scholar
  100. Sithole BB, Guy RD (1987) Models for tetracycline in aquatic environments. I. Interaction with bentonite clay systems. Water Air Soil Pollut 32:303–314.Google Scholar
  101. Snyder SA, Westerhoff P, Yoon Y, Sedlak DL (2003) Pharmaceuticals, personal care products and endocrine disrupters in water: implications for water treatment. Environ Eng Sci 20:449–469.Google Scholar
  102. Sörgel F, Kinzig M (1993) Pharmacokinetics of gyrase inhibitors. Part 2: Renal and hepatic elimination pathways and drug interactions. Am J Med 94:56–69.Google Scholar
  103. Sørum H, L’Abée-Lund TM (2002) Antibiotic resistance in food-related bacteria a result of interfering with the global web of bacterial genetics. Int J Food Microbiol 78:43–56.Google Scholar
  104. Spaepen KRI, Van Leemput LJJ, Wislocki PG, Verschueren C (1997) A uniform procedure to estimate the predicted environmental concentration of the residues of veterinary medicines in soil. Environ Toxicol Chem 16:1977–1982.Google Scholar
  105. Stamatelatou K, Lyberatos G, Drillia P (2003) The fate of pharmaceuticals on soil. Presented at ENVIRPHARMA, European Conference on Human and Veterinary Pharmaceuticals in the Environment, Lyon, France, April 14–16, 2003.Google Scholar
  106. Sudo K, Okazaki O, Tsumura M, Tachizawa H (1986) Isolation and identification of metabolites of ofloxacin in rats, dogs, and monkeys. Xenobiotica 16:725–732.Google Scholar
  107. Sunderland J, Tobin CM, White LO, MacGowan AP, Hedges AJ (1999) Ofloxacin photodegradation products possess antimicrobial activity. Drugs 58:171–172.Google Scholar
  108. Sunderland J, Tobin CM, Hedges AJ, MacGowan AP, White LO (2001) Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography. J Antimicrob Chemother 47:271–275.Google Scholar
  109. Thiele-Bruhn S (2003) Pharmaceutical antibiotic compounds in soils-a review. J Plant Nutr Soil Sci 166:145–167Google Scholar
  110. Thurman EM, Dietze LE, Scribner EA (2002) Occurrence of antibiotics in water from fish hatcheries. Fact Sheet 120-02. U.S. Geological Survey, Washington, DC.Google Scholar
  111. Tolls J (2001) Sorption of veterinary pharmaceuticals in soils: a review. Environ Sci Technol 35:3397–3406.Google Scholar
  112. Tyczkowska K, Hedeen KM, Aucoin DP, Aronson AL (1989) High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. J Chromatogr 493:337–346.Google Scholar
  113. Van Dijk J, Keukens HJ (2000) The stability of some veterinary drugs and coccidiostats during composting and storage of laying hen and broiler feces. In: Van Ginkel LA, Ruiter A (eds) Residues of Veterinary Drugs in Food. Proceedings of the Euroresidue IV Conference, Veldhoven, The Netherlands, May 8–10, 2000, pp 356–360.Google Scholar
  114. Van Hoof N, Wasch KD, Okerman L, Reybroeck W, Poelmans S, Noppe H, Brabander HD (2005) Validation of a liquid chromatography-tandem mass spectrometric method for the quantification of eight quinolones in bovine muscle, milk and aquacultured products. Anal Chim Acta 529:265–272.Google Scholar
  115. Van Saene JJM, Van Saene HKF, Lerk CF (1986) Inactivation of quinolone by feces. J Infect Dis 153:999–1000.Google Scholar
  116. Velagaleti RR, Davis ML, O’Brien GK, Stamm JM (1993) The bioavailability of 14C-sarafloxacin hydrochloride in three soils and a marine sediment as determined by biodegradation and sorption/desorption parameters. In: Abstracts of the 205th National Meeting of the American Chemical Society, Division of Agrochemicals, American Chemical Society, Washington, DC, Abstract 92.Google Scholar
  117. Vílchez JL, Araujo L, Prieto A, Navalón A (2004) Determination of ciprofloxacin and enoxacin in human serum samples by micellar liquid chromatography. Anal Chim Acta 516:135–140.Google Scholar
  118. Walker RA, Lawson AJ, Lindsay EA, Ward LR, Wright PA, Bolton FJ, Wareing DR, Corkish JD, Davies RH, Threlfall EJ (2000) Decreased susceptibility to cipro-floxacin in outbreak-associated multi-resistant Salmonella typhimurium DT 104. Vet Rec 147:395–396.Google Scholar
  119. Wang PL, Chen L, Fan YF (2001) Selective separation and simultaneous determination of trace levels of five types of fluorinated quinolone drugs by thin-layer chromatography/fluorescence densiometry. J AOAC Int 84:684–688.Google Scholar
  120. Wetzstein HG (2001) Chinolone in der Umwelt: Biologische Abbaubarkeit der Gyrasehemmer. Pharm Unserer Zeit 30:450–457.Google Scholar
  121. Wetzstein H-G, Schmeer N, Karl W (1997) Degradation of fluoroquinolone enro-floxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites. Appl Environ Microbiol 63:4272–4281.Google Scholar
  122. Wetzstein H-G, Stadler M, Tichy H-V, Dalhoff A, Karl W (1999) Degradation of ciprofloxacin by basidomycetes and identification of metabolites generated by the brown rot fungus Gloeophyllum striatum. Appl Environ Microbiol 65:1556–1563.Google Scholar
  123. Wetzstein H-G, Karl W, Hallenbach W, Himmler T, Petersen U (2000) Residual antibacterial activity of metabolites derived from the vetrinary fluoroquinolone enrofloxacin. 100th General Meeting of the American Society for Microbiology, Los Angeles, CA.Google Scholar
  124. WHO (1998) Use of quinolones in food animals and potential impact on human health. WHO/EMC/ZDI/98.10. Report of a WHO Meeting, Geneva, Switzerland, June 2–5, 1998.Google Scholar
  125. Williams AJ, Parshikov IA, Moody JD, Heinze TM, Sutherland JB (2004) Fungal transformation of an antimicrobial fluoroquinolone drug during growth on poultry litter materials. J Appl Poult Res 13:235–240.Google Scholar
  126. Wise R (2002) Antimicrobial resistance: priorities for action. J Antimicrob Chemother 49:585–586.Google Scholar
  127. Xifra I (2000) Behaviour of ciprofloxacin and norfloxacin during wastewater treatment. ETH, Zurich, Switzerland.Google Scholar
  128. Zeiler H-J, Peterson U, Gau W, Ploschke HJ (1987) Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay. Arzneim Forschung/Drug Res 37:131–134.Google Scholar
  129. Zhang H, Huang C-H (2005) Oxidative transformation of fluoroquinolone antibacterial agents and structurally related amines by manganese oxide. Environ Sci Technol 39:4474–4483.Google Scholar
  130. Zuccato E, Castiglioni S, Fanelli R, Bagnati R, Calamari D (2004) Pharmaceuticals in the environment: changes in the presence and concentrations of pharmaceuticals for human use in Italy. In: Kümmerer K (ed) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 2nd Ed. Springer-Verlag, Berlin, pp 45–53.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Premasis Sukul
    • 1
  • Michael Spiteller
    • 1
  1. 1.Institute of Environmental Research (INFU)University of DortmundDortmundGermany

Personalised recommendations